Clinical Trials Browser

Recruiting × Leukemia, Myelomonocytic, Chronic × CPX-351 × Clear all

NCT03896269 2026-02-20

CPX-351 in Treating Patients With Relapsed or Refractory High Risk Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia

Phase 1 Recruiting

Other hematologic neoplasm

Leukemia, Myelomonocytic, Chronic